These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 21169410)
1. The metastasis-associated microRNA miR-516a-3p is a novel therapeutic target for inhibiting peritoneal dissemination of human scirrhous gastric cancer. Takei Y; Takigahira M; Mihara K; Tarumi Y; Yanagihara K Cancer Res; 2011 Feb; 71(4):1442-53. PubMed ID: 21169410 [TBL] [Abstract][Full Text] [Related]
2. Development and biological analysis of peritoneal metastasis mouse models for human scirrhous stomach cancer. Yanagihara K; Takigahira M; Tanaka H; Komatsu T; Fukumoto H; Koizumi F; Nishio K; Ochiya T; Ino Y; Hirohashi S Cancer Sci; 2005 Jun; 96(6):323-32. PubMed ID: 15958054 [TBL] [Abstract][Full Text] [Related]
3. Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer. Kurashige J; Mima K; Sawada G; Takahashi Y; Eguchi H; Sugimachi K; Mori M; Yanagihara K; Yashiro M; Hirakawa K; Baba H; Mimori K Carcinogenesis; 2015 Jan; 36(1):133-41. PubMed ID: 25411357 [TBL] [Abstract][Full Text] [Related]
4. Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Hippo Y; Yashiro M; Ishii M; Taniguchi H; Tsutsumi S; Hirakawa K; Kodama T; Aburatani H Cancer Res; 2001 Feb; 61(3):889-95. PubMed ID: 11221876 [TBL] [Abstract][Full Text] [Related]
5. MicroRNAs Associated with Epithelial-Mesenchymal Transition Can Be Targeted to Inhibit Peritoneal Dissemination of Human Scirrhous Gastric Cancers. Takei Y; Shen G; Morita-Kondo A; Hara T; Mihara K; Yanagihara K Pathobiology; 2018; 85(4):232-246. PubMed ID: 29847827 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers. Zheng B; Liang L; Huang S; Zha R; Liu L; Jia D; Tian Q; Wang Q; Wang C; Long Z; Zhou Y; Cao X; Du C; Shi Y; He X Oncogene; 2012 Oct; 31(42):4509-16. PubMed ID: 22179828 [TBL] [Abstract][Full Text] [Related]
7. Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance. Hashiguchi Y; Nishida N; Mimori K; Sudo T; Tanaka F; Shibata K; Ishii H; Mochizuki H; Hase K; Doki Y; Mori M Int J Oncol; 2012 May; 40(5):1477-82. PubMed ID: 22322911 [TBL] [Abstract][Full Text] [Related]
8. Intraperitoneal administration of an adenovirus vector carrying REIC/Dkk-3 suppresses peritoneal dissemination of scirrhous gastric carcinoma. Than SS; Kataoka K; Sakaguchi M; Murata H; Abarzua F; Taketa C; Du G; Yashiro M; Yanagihara K; Nasu Y; Kumon H; Huh NH Oncol Rep; 2011 Apr; 25(4):989-95. PubMed ID: 21249317 [TBL] [Abstract][Full Text] [Related]
9. A novel transforming growth factor beta receptor kinase inhibitor, A-77, prevents the peritoneal dissemination of scirrhous gastric carcinoma. Kawajiri H; Yashiro M; Shinto O; Nakamura K; Tendo M; Takemura S; Node M; Hamashima Y; Kajimoto T; Sawada T; Ohira M; Hirakawa K Clin Cancer Res; 2008 May; 14(9):2850-60. PubMed ID: 18451253 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor. Zhao X; Dou W; He L; Liang S; Tie J; Liu C; Li T; Lu Y; Mo P; Shi Y; Wu K; Nie Y; Fan D Oncogene; 2013 Mar; 32(11):1363-72. PubMed ID: 22614005 [TBL] [Abstract][Full Text] [Related]
11. ICAM-2 gene therapy for peritoneal dissemination of scirrhous gastric carcinoma. Tanaka H; Yashiro M; Sunami T; Sakate Y; Kosaka K; Hirakawa K Clin Cancer Res; 2004 Jul; 10(14):4885-92. PubMed ID: 15269165 [TBL] [Abstract][Full Text] [Related]
12. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas. Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450 [TBL] [Abstract][Full Text] [Related]
13. Transduction of soluble Flt-1 gene to peritoneal mesothelial cells can effectively suppress peritoneal metastasis of gastric cancer. Sako A; Kitayama J; Koyama H; Ueno H; Uchida H; Hamada H; Nagawa H Cancer Res; 2004 May; 64(10):3624-8. PubMed ID: 15150121 [TBL] [Abstract][Full Text] [Related]
14. miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer. Guo X; Guo L; Ji J; Zhang J; Zhang J; Chen X; Cai Q; Li J; Gu Q; Liu B; Zhu Z; Yu Y Biochem Biophys Res Commun; 2010 Jul; 398(1):1-6. PubMed ID: 20510161 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA expression profiles in human colorectal cancers with liver metastases. Lin M; Chen W; Huang J; Gao H; Ye Y; Song Z; Shen X Oncol Rep; 2011 Mar; 25(3):739-47. PubMed ID: 21174058 [TBL] [Abstract][Full Text] [Related]
16. HIF-1α is a crucial factor in the development of peritoneal dissemination via natural metastatic routes in scirrhous gastric cancer. Miyake S; Kitajima Y; Nakamura J; Kai K; Yanagihara K; Tanaka T; Hiraki M; Miyazaki K; Noshiro H Int J Oncol; 2013 Nov; 43(5):1431-40. PubMed ID: 23970191 [TBL] [Abstract][Full Text] [Related]
17. Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22. Patel JB; Appaiah HN; Burnett RM; Bhat-Nakshatri P; Wang G; Mehta R; Badve S; Thomson MJ; Hammond S; Steeg P; Liu Y; Nakshatri H Oncogene; 2011 Mar; 30(11):1290-301. PubMed ID: 21057539 [TBL] [Abstract][Full Text] [Related]
18. CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis. Guled M; Lahti L; Lindholm PM; Salmenkivi K; Bagwan I; Nicholson AG; Knuutila S Genes Chromosomes Cancer; 2009 Jul; 48(7):615-23. PubMed ID: 19396864 [TBL] [Abstract][Full Text] [Related]
19. [Potential role of ezrin and its related microRNA in ovarian cancer invasion and metastasis]. Li J; Liang SH; Lu X Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):787-92. PubMed ID: 21176563 [TBL] [Abstract][Full Text] [Related]
20. HER2 interacts with CD44 to up-regulate CXCR4 via epigenetic silencing of microRNA-139 in gastric cancer cells. Bao W; Fu HJ; Xie QS; Wang L; Zhang R; Guo ZY; Zhao J; Meng YL; Ren XL; Wang T; Li Q; Jin BQ; Yao LB; Wang RA; Fan DM; Chen SY; Jia LT; Yang AG Gastroenterology; 2011 Dec; 141(6):2076-2087.e6. PubMed ID: 21925125 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]